tiprankstipranks
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
Holding KNSA?
Track your performance easily

Kiniksa Pharmaceuticals (KNSA) Cash flow

432 Followers

Kiniksa Pharmaceuticals Cash Flow

KNSA's free cash flow for Q3 2024 was $-2.24M. For the 2024 fiscal year, KNSA's free cash flow was decreased by $7.38M and operating cash flow was $-2.24M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 24.24M$ 13.30M$ 5.81M$ -126.30M$ -136.53M$ -158.37M
Investing Cash Flow
$ -80.32M$ -29.56M$ -8.08M$ 128.63M$ -23.44M$ 49.21M
Financing Cash Flow
$ 7.76M$ 1.50M$ 2.52M$ 5.88M$ 227.09M$ 84.11M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 422.43M$ 107.95M$ 122.72M$ 122.47M$ 114.25M$ 72.19M
Income Tax Paid Supplemental Data
$ -370.00K$ 5.61M$ 10.69M$ 1.28M$ 482.00K$ 1.72M
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
----$ 443.34M$ 166.21M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ 19.93M$ 13.17M$ 5.79M$ -146.71M$ -136.81M$ -161.57M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Kiniksa Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis